Related Experiment Video
Updated: Aug 27, 2025

10:01
Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
Published on: October 17, 2018
8.1K
Understanding the Tissue Specificity of ZIKV Infection in Various Animal Models for Vaccine Development
1Department of Biomedical Science and Engineering, Konkuk University, Seoul 05029, Korea.
Vaccines
|September 23, 2022
Summary
Understanding Zika virus (ZIKV) tissue tropism in animal models is crucial for developing effective vaccines and treatments. This review details ZIKV
Area of Science:
- Virology
- Immunology
- Pathogenesis
Background:
- Zika virus (ZIKV), a Flavivirus transmitted by Aedes mosquitoes, causes mild to severe symptoms, including microcephaly and neurological disorders.
- Current therapeutic and vaccine options for ZIKV infection are limited.
- ZIKV primarily targets the placenta, leading to vertical transmission, but also affects multiple tissues in adults.
Purpose of the Study:
- To comprehensively review and discuss the tissue specificity of ZIKV across various animal models.
- To highlight how genetic background and administration routes influence ZIKV tropism in different models.
- To guide the selection of appropriate animal models for ZIKV research.
Main Methods:
- Literature review of studies reporting ZIKV tissue tropism in animal models.
- Analysis of ZIKV pathogenesis based on host genetic factors.
- Evaluation of ZIKV dissemination patterns according to administration routes.
Main Results:
- ZIKV exhibits distinct tissue tropism patterns that vary among animal models.
- Host genetic background significantly influences ZIKV pathogenesis and tissue distribution.
- Route of ZIKV administration affects viral spread and target organs.
Conclusions:
- Understanding animal model-specific ZIKV tropism is essential for accurate pathogenesis studies.
- Informed animal model selection will enhance the design of preclinical and clinical studies.
- This review supports the development of targeted ZIKV vaccines and therapeutics.

